Oxford BioTherapeutics Takes Exclusive Rights to Use Xenomouse® Antibodies and ADC Technology

News   May 16, 2014

 
Oxford BioTherapeutics Takes Exclusive Rights to Use Xenomouse® Antibodies and ADC Technology
 
 
 

RELATED ARTICLES

Dietary Fat Metabolism May Promote Metastasis

News

A new study has highlighted links between dietary fat and prostate cancer, suggesting a high-fat Western diet may encourage tumour metastasis.

READ MORE

Multidisciplinary Study Suggests New Strategy for Drug Discovery

News

A joint industry/academia study of a cancer target protein reveals unusual relation between binding site flexibility and drug-target lifetime. The results, , suggest a new strategy for drug discovery.

READ MORE

Cold and Flu Season is Well Under Way But Don't Stifle a Sneeze Warn Doctors

News

Pinching your nose while clamping your mouth shut to contain a forceful sneeze isn't a good idea, warn doctors. One young man managed to rupture the back of his throat during this manoeuvre, leaving him barely able to speak or swallow, and in considerable pain.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE